Medical, Alzheimer's | featured news

The new class of drug, which can be taken orally, is designed to protect the brain by combating the damaging effects of inflammation. Results from early stage clinical trials have yet to be announced, but studies on animals suggest the therapy could be effective against a wide range of conditions which also include motor neurone disease and complications from traumatic brain injury.

The tantalising prospect of treating a range of brain diseases, such as Alzheimer's and Parkinson's, all with the same drug has been raised by UK researchers.

Scientists are closing in on a long-sought goal: A blood test to screen people for Alzheimer's disease. An experimental test did a good job of indicating how much of the telltale Alzheimer's plaque lurks in people's brains, Australian researchers reported Wednesday. If the test proves accurate in larger studies, it could offer a way to check people having memory problems to see who needs more definitive testing for the disease.

An essential nutrient found in fish oil does not appear to slow the mental decline associated with Alzheimer's disease, according to a new study in the Journal of the American Medical Association.

A simple blood test could diagnose Alzheimer's disease, U.S. researchers said Monday, a finding that could give more people a chance to be tested.

The spice has been used in clinical trials like the one published in the Journal of Neurochemistry that reported on a 30% decrease in the size of Alzheimer's associated brain plaque in treated subjects in just one week.